Trial · NCT02108652
Adverse events198
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 198
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | MPDL3280A COHORT2 INFUSION | 56 | 310 | 72 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 44 | 310 | 54 |
| other | CONSTIPATION | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 85 | 310 | 102 |
| other | DIARRHOEA | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 69 | 310 | 103 |
| other | DRY MOUTH | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 24 | 310 | 25 |
| other | NAUSEA | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 86 | 310 | 114 |
| other | VOMITING | Gastrointestinal disorders | MPDL3280A COHORT2 INFUSION | 61 | 310 | 83 |
| other | ASTHENIA | General disorders | MPDL3280A COHORT2 INFUSION | 23 | 310 | 37 |
| other | CHILLS | General disorders | MPDL3280A COHORT2 INFUSION | 34 | 310 | 37 |
| other | FATIGUE | General disorders | MPDL3280A COHORT2 INFUSION | 164 | 310 | 228 |
| other | INFLUENZA LIKE ILLNESS | General disorders | MPDL3280A COHORT2 INFUSION | 17 | 310 | 65 |
| other | OEDEMA PERIPHERAL | General disorders | MPDL3280A COHORT2 INFUSION | 52 | 310 | 63 |
| other | PAIN | General disorders | MPDL3280A COHORT2 INFUSION | 27 | 310 | 34 |
| other | PYREXIA | General disorders | MPDL3280A COHORT2 INFUSION | 70 | 310 | 90 |
| other | NASOPHARYNGITIS | Infections and infestations | MPDL3280A COHORT2 INFUSION | 19 | 310 | 25 |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | MPDL3280A COHORT2 INFUSION | 23 | 310 | 28 |
| other | URINARY TRACT INFECTION | Infections and infestations | MPDL3280A COHORT2 INFUSION | 62 | 310 | 94 |
| other | ALANINE AMINOTRANSFERASE INCREASED | Investigations | MPDL3280A COHORT2 INFUSION | 16 | 310 | 24 |
| other | BLOOD ALKALINE PHOSPHATASE INCREASED | Investigations | MPDL3280A COHORT2 INFUSION | 19 | 310 | 20 |
| other | BLOOD CREATININE INCREASED | Investigations | MPDL3280A COHORT2 INFUSION | 22 | 310 | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02108652/events